The oversubscribed round included Pfizer, Novartis, Merck Group and AbbVie, and boosted the cancer drug developer's overall funding to $120m.

Illumina, GV and Orient Life supported a $72m series C round for MIT spinout SQZ Biotechnology, with the money set to fund therapies for solid tumours and autoimmunity.

NGP Capital led a series C round for the on-demand delivery services provider that included Qualcomm Ventures, taking its total funding to about $41m.

Illumina, GV and Orient Life supported a $72m series C round for SQZ Biotechnology, with the money set to fund therapies for solid tumours and autoimmunity.

Existing investor Center Laboratories Group contributed to Tot's series B round, which will fund development of its oncology treatments.

The digital therapy developer added $13m from backers including Digital Garage to a series C round already featuring Amgen and Merck Group.

The Tencent-backed online Q+A platform was originally reported to have raised $300m in the round last month.

The co-working space provider has secured $1bn in convertible note financing from long-term investor SoftBank despite heavy 2018 losses.

Therachon has welcomed back Inserm Transfert Initiative for its series B round, led by Novo.

Founded by two UC Berkeley graduates, DNAlite Therapeutics has been backed by the university and its Berkeley Catalyst Fund.